While there is no cure, multiple myeloma treatment options are available, with new methods emerging every year. Oncologists use a combination of factors and therapies to create a personalized treatment plan. Each treatment plan is designed to help individuals manage the disease, alleviate symptoms, and improve their quality of life. Knowing what to expect and what options are available can help you work with your oncology team and make informed decisions about your medical care.
Multiple myeloma is a diverse group of diseases. Oncologists need to make an accurate diagnosis and design an appropriate treatment plan. The oncology team will order blood tests, bone marrow biopsies, and detailed imaging scans. These tests help determine the extent of the disease and allow the oncologist to select the most appropriate treatment plan.
Once they confirm the diagnosis, the oncologist will discuss available treatment options and outline a strategy tailored to the patient's condition goals. These goals will often include the following guidelines:
For newly diagnosed patients with multiple myeloma, the oncology team will follow a standard of care called induction therapy. After induction therapy, the oncologist will determine if the patient is eligible for an autologous stem cell transplant (ASCT). Then, treatment will continue through maintenance and supportive care.
Induction therapy is the front-line method that oncologists use in multiple myeloma treatment. According to the Multiple Myeloma Research Foundation, this stage in treatment typically consists of a three-drug or four-drug combination regiment given over three to four cycles. The treatment cycles typically last 3 to 4 weeks.
The initial treatment method depends on a variety of factors. These include the features of the patient's myeloma, the risk of side effects, and personal preferences. The oncologist will also need to determine if the patient is a candidate for high-dose chemotherapy followed by an autologous stem cell transplant (ASCT). If they are eligible and decide to proceed with the transplant, they will undergo induction therapy followed by stem cell collection and storage, high-dose melphalan chemotherapy, and ASCT. The patient will then receive maintenance treatment.
If the patient is not eligible for ASCT, they will go directly from induction therapy to maintenance treatment. However, the timing will depend on their response to induction therapy. The oncology team will help determine which course of treatment is best for them based on their needs and treatment goals.
For eligible patients, oncologists often recommend ASCT after induction therapy. During this procedure, healthy stem cells are collected from the patient for immediate or future use. The oncologist then administers high-dose chemotherapy to eliminate any remaining myeloma cells. Finally, they will reinfuse the harvested stem cells to restore the function of the patient's bone marrow. ASCT, when combined with high-dose chemotherapy, offers a very good opportunity for a long-lasting response.
This stage of multiple myeloma treatment includes lower doses of medications such as immunomodulatory drugs or targeted therapies. The oncologist will monitor the patient's response to maintenance therapy through regular blood tests, bone marrow biopsies, and imaging tests to track the progression of the disease. Long-term monitoring and follow-up care can help patients and their doctors manage their multiple myeloma and detect any signs of recurrence. Patients will have regular follow-up appointments with their oncologist to assess their response to treatment and adjust the plan if necessary.
Some patient's multiple myeloma is resistant to therapy (refractory) or may return after remission (relapsed). Fortunately, there are many effective treatment options for this type of multiple myeloma. These methods are based on the number of prior myeloma treatments already received and that no longer work. Some treatments are used for patients with three or fewer previous treatments (referred to as being in early relapse), while other treatments are used for patients with more than three previous therapies. Certain factors, such as prior ASCT, aggressiveness of relapse, and prior treatments, will determine the type of refractory or relapsed multiple myeloma treatment.
Multiple myeloma treatment can cause side effects that vary from person to person. Common side effects include:
It is important for patients to regularly communicate their concerns and experiences with their oncology team during their treatment to mitigate the effects on their overall quality of life. The oncologist may prescribe supportive medications to alleviate these symptoms and recommend lifestyle adjustments to improve overall well-being.
Multiple myeloma treatment is a multifaceted process that requires careful planning and ongoing professional medical guidance. Do you have questions about Lindenberg Cancer & Hematology Center 's treatment options? Call our Marlton office to learn more or to schedule a consultation.
Request an appointment here: https://lindenbergcancer.com or call Lindenberg Cancer & Hematology Center at (856) 475-0876 for an appointment in our Marlton office.
Check out what others are saying about our services on Yelp: Multiple Myeloma Treatment in Marlton, NJ.
Anemia occurs when the body does not have enough healthy red blood cells to carry oxygen efficiently. This can lead to fatigue, weakness, and difficulty performing daily activities. While medical treatment is often necessary, diet and lifestyle changes can play an important role in managing symptoms and supporting overall health. Eating the right foods and…
Breast cancer treatment involves a range of therapies designed to address the disease while promoting overall well-being. With the right strategies, it is possible to manage breast cancer and even put it into remission. With a few tips from an oncologist, patients can find practical ways to enhance physical and emotional health at every stage…
An ovarian cancer diagnosis is often overwhelming and frightening. However, advancements in science and medicine provide hope for remission with effective ovarian cancer treatment. As you navigate this challenging journey, your gynecologist can help guide you through various treatment options. These options can empower you to make informed decisions about your health.Surgery is usually the…
With a variety of medical advancements available, oncologists design prostate cancer treatment options to address the specific needs of each patient. These approaches aim to manage the condition effectively while considering the patient's overall well-being. Receiving care tailored to the patient can help ensure that treatments align with each patient's health goals and preferences. A…
Anemia occurs when the body does not have enough healthy red blood cells to carry…
Surgery is usually the first line of treatment for ovarian cancer. The extent of the…
Breast cancer treatment involves a range of therapies designed to address the disease while promoting…
With a variety of medical advancements available, oncologists design prostate cancer treatment options to address…
Incorporating the skills of a hematologist into an oncology treatment plan offers a valuable layer…
A cancer center is a place of hope, care, and expertise. Remember that the care…
